Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Genesis Lifestyle Medicine vs Lyfe Rx

Genesis Lifestyle Medicine
Graded #392

Lower grade

vs+0.5999999999999943
Lyfe Rx
Graded #375

Higher grade

The verdict

Lyfe Rx takes it — 58.3/100 to 57.7/100, but only just.

Lyfe Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lyfe Rx offers compounded semaglutide ($289) and compounded tirzepatide ($399). Genesis Lifestyle Medicine is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLyfe Rx +5
45
50
Dose & formulationLyfe Rx +11
53
64
Clinical oversightGenesis Lifestyle Medicine +11
78
67
Labs & monitoringEven
52
52
FulfillmentGenesis Lifestyle Medicine +5
67
62
Contract termsEven
55
55
Genesis Lifestyle Medicine · left barLyfe Rx · right bar

The numbers

MetricGenesis Lifestyle MedicineLyfe Rx
WeighScore57.7/10058.3/100
GradeCC
Scorecard rank#392#375
SemaglutideNot disclosed$225/mo (compounded)
TirzepatideNot disclosed$299/mo (compounded)
Coverage8 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only

Strengths

  • 18 physical clinics allow in-person consults and injections across 8 states
  • Dual modality — compounded sema/tirz plus brand-name Wegovy and Zepbound on one platform
  • Med spa model lets patients combine weight loss, hormone therapy, and aesthetics
  • Established brand with an 18-location footprint and patient testimonials
  • Telehealth available for remote patients in served states

Where it loses points

  • Pricing not disclosed publicly — gated behind the consultation flow
  • Specific 503A/503B pharmacy partner not named, and the designation not specified
  • No FDA compounded-medication disclaimer visible on the homepage
  • Named medical director not formally disclosed (only a 'Dr. Spinoso' testimonial)
  • Corporate legal entity and governing law not disclosed
Lyfe Rx

Graded #375 · C

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Delivery to all 50 states with 1–3 day pharmacy turnaround

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • Also sells non-prescription supplements ('Tirzepatide Weight Loss Supplement', 'Lipo Burn')
  • Shopify-based e-commerce storefront — less clinical infrastructure
  • FDA issued this company a warning letter dated 9 September 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard